2000
DOI: 10.1016/s0196-9781(99)00177-1
|View full text |Cite
|
Sign up to set email alerts
|

Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
45
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(46 citation statements)
references
References 48 publications
1
45
0
Order By: Relevance
“…Treatment with VIP, PACAP, UCN, AM, CST or GHR delays the onset, increases survival and reduces the severity of various experimental models of sepsis [34,35,36,37,38], collagen-induced arthritis [39,40,41,42], inflammatory bowel disease [43,44,45,46], multiple sclerosis [47,48,49], type I diabetes mellitus [50], Sjögren’s syndrome [51], pancreatitis [52,53] and uveoretinitis [54,55] (table 1). The therapeutic effect of these neuropeptides is associated with the reduction of the two main phases of these diseases.…”
Section: Endogenous Anti-inflammatory Neuropeptides With An Immunomodmentioning
confidence: 99%
See 1 more Smart Citation
“…Treatment with VIP, PACAP, UCN, AM, CST or GHR delays the onset, increases survival and reduces the severity of various experimental models of sepsis [34,35,36,37,38], collagen-induced arthritis [39,40,41,42], inflammatory bowel disease [43,44,45,46], multiple sclerosis [47,48,49], type I diabetes mellitus [50], Sjögren’s syndrome [51], pancreatitis [52,53] and uveoretinitis [54,55] (table 1). The therapeutic effect of these neuropeptides is associated with the reduction of the two main phases of these diseases.…”
Section: Endogenous Anti-inflammatory Neuropeptides With An Immunomodmentioning
confidence: 99%
“…Neuropeptides also modulate inflammatory responses through the regulation of different functions of mast cells, such as degranulation [38,67,68,69]. …”
Section: Endogenous Anti-inflammatory Neuropeptides With An Immunomodmentioning
confidence: 99%
“…Recently, from the large number of soluble inflammatory mediators and different cellular effector populations implicated in the onset of arthritis, mast cells have been proven to be the cellular link between soluble factors and inflammatory arthritis (Lee et al, 2002). In general, VIP and PACAP cause histamine release from mast cells (Lowman et al, 1988;Benyon et al, 1989;Mousli et al, 1994;Ottosson and Edvinsson, 1997;Odum et al, 1998), but other effects have been also reported (Tuncel et al, 2000), probably reflecting the functional heterogeneity of mast cells.…”
Section: B Biochemical Pharmacological and Signaling Key Features mentioning
confidence: 99%
“…Furthermore, additional mechanisms could be participating in the therapeutic effect of VIP on endotoxemia. Indeed, other studies (Tuncel and Tore, 1998;Tuncel et al, 2000) suggested that the protective effect of VIP on septic shock syndrome is mediated through the regulation of serum levels of hormones, such as adrenaline and cortisol, which control hemodynamic constants, important events in the pathology of sepsis.…”
Section: A Septic Shockmentioning
confidence: 99%
“…Both reside in the gastrointestinal tract and central nervous system. Also, SP [6] and VIP [7] are interactive signaling molecules between the nervous system and the immune system. SP and VIP could regulate the function of intestinal mucosal mast cells by regulating neurosecretion and paracrine secretion.…”
Section: Introductionmentioning
confidence: 99%